| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $31.5M | +3.3% |
| Cost of Revenue | $17.7M | -3.2% |
| Gross Profit | $13.8M | +13.0% |
| R&D Expense | $1.9M | +0.8% |
| SG&A Expense | $6.7M | +24.8% |
| Operating Income | $836K | +231.3% |
| Pre-tax Income | -$19K | +93.0% |
| Income Tax | -$70K | -144.1% |
| Net Income | $51K | +111.6% |
| EPS (Basic) | -$0.02 | +98.5% |
| EPS (Diluted) | -$0.02 | +98.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $8.6M | +14.9% |
| Inventory | $14.1M | +7.0% |
| Current Assets | $23.5M | — |
| Total Assets | $27.6M | — |
| Current Liabilities | $9.5M | -29.3% |
| Total Liabilities | $18.7M | +2294.5% |
| Stockholders' Equity | $7.2M | +1036.8% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.2M | +14.8% |
| Capital Expenditures | $582K | -13.2% |
| Investing Cash Flow | -$1.2M | -47.1% |
| Financing Cash Flow | $590K | +226.6% |
| Free Cash Flow | $601K | +67.0% |